ZIF-8-gated cascade nanoreactor amplifies glucose-triggered CO release and ferroptosis for mild photothermal cancer therapy.

Authors

Haiyan Chen, Tianqing Jiang, Yibin Zhang, Ling Mei, Yujie Mao

Published in

Materials today. Bio. Volume 41. Pages 103724. Epub Oct 05, 2026.

Abstract

Mild photothermal therapy offers a safer alternative to conventional hyperthermia, but its therapeutic efficacy is frequently compromised by heat-shock protection, metabolic compensation and insufficient intracellular oxidative damage. Herein, we developed a ZIF-8-gated cascade nanoreactor, denoted ZIF/HMPB-CO@GOx, to amplify glucose-triggered carbon monoxide release and ferroptosis for enhanced mild photothermal cancer therapy. In this system, hollow mesoporous photothermal nanocores were loaded with a CO donor and glucose oxidase, followed by ZIF-8 coating as an acid-responsive gatekeeper. The ZIF-8 shell protected the catalytic payloads under physiological conditions and promoted intracellular release in acidic environments. Upon 808 nm laser irradiation, the nanoreactor generated nonablative mild hyperthermia and accelerated cascade reactions in which GOx catalyzed glucose oxidation to produce H₂O₂, thereby coupling glucose metabolism to CO liberation and redox amplification. The combined metabolic actions suppressed glycolysis and mitochondrial oxidative phosphorylation, resulting in ATP depletion and lactate reduction; these changes were accompanied by reduced HSP70 protein abundance. Meanwhile, GSH depletion, reduced GPX4 protein abundance and lipid-peroxidation-associated readouts supported ferroptotic involvement, together with partial rescue by ferrostatin-1. In 4T1 tumor-bearing mice, ZIF/HMPB-CO@GOx enabled tumor accumulation, controlled mild photothermal heating and pronounced tumor growth suppression without obvious body-weight loss. This ZIF-8-gated nanoreactor establishes a glucose-powered gas-releasing strategy to reduce reliance on high-temperature thermal ablation while coupling metabolic disruption with ferroptosis-related oxidative damage.

PMID:
42898095
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.